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STRUCTURED ABSTRACT: 
OBJECTIVES: We examined clinical outcomes following percutaneous coronary intervention 
(PCI) in patients turned down for surgical revascularization across a broad population. 
BACKGROUND:  Prior studies suggest that surgical ineligibility is associated with increased 
mortality in patients with unprotected left main or multivessel coronary artery disease 
undergoing PCI.  
METHODS: This study included consecutive patients who underwent PCI in a multicenter 
registry in Michigan from 1/2010 – 12/2014. Surgical ineligibility required documentation 
indicating that a cardiac surgeon deemed the patient ineligible for surgery. In-hospital outcomes 
included mortality (primary outcome), cardiogenic shock, cerebrovascular accident, contrast-
induced nephropathy (CIN), and a new requirement for dialysis (NRD). 
RESULTS: Of 99,370 patients at 33 hospitals with on-site surgical backup, 1,922 (1.9%) were 
surgically ineligible. The rate of ineligibility did not vary by hospital (range: 1.5%-2.5%; p=0.79). 
Overall, there were no major differences in baseline characteristics or outcomes between 
surgically ineligible patients and the rest (i.e. non-ineligible patients): mortality (0.52% vs. 
0.52%; p>0.5), cardiogenic shock (0.68% vs. 0.73%; p>0.5), cerebrovascular accident (0.05% vs. 
0.19%; p=0.28), NRD (0.16% vs. 0.19%; p>0.5), CIN (2.7% vs. 2.3%; p=0.27). Among 1,074 
patients who underwent unprotected left main PCI, 20 (1.9%) were surgically ineligible and 
experienced increased rates of mortality (20.0% vs. 5.3%; p=0.022; adjusted OR = 7.38; p<0.001) 
and other complications as compared to the remainder.  
CONCLUSIONS: PCI in a broad population of surgically ineligible patients is generally safe. 
However, among patients who underwent unprotected left main PCI, those deemed surgically 
ineligible experienced significantly worse outcomes as compared to the rest.  
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KEY WORDS: percutaneous coronary intervention (PCI); coronary artery bypass grafting; health 
care outcomes; risk stratification; coronary artery disease 
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CONDENSED ABSTRACT: Using a large, multicenter, regional registry of PCI, this study examined 
the relationship between surgical ineligibility and clinical outcomes after PCI. In the overall study 
cohort (n = 99,370), PCI appears to be safe in surgically ineligible patients as there was no 
significant difference in outcomes between ineligible patients as compared to the rest. 
Importantly, surgical ineligibility was associated with worse outcomes in patients undergoing 
unprotected left main PCI.  
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ABBREVIATIONS & ACRONYMS: 
CAD = coronary artery disease 
PCI = percutaneous coronary intervention 
CABG = coronary artery bypass grafting 
BMC2 = Blue Cross Blue Shield of Michigan Cardiovascular Consortium 
STEMI = ST-elevation myocardial infarction 
NCDR = National Cardiovascular Data Registry 
NRD = new requirement for dialysis 
CVA = cerebrovascular accident 
CIN = contrast-induced nephropathy 
LAD = left anterior descending artery 
NSTEMI = Non ST-elevation myocardial infarction 
GFR = glomerular filtration rate 
IABP = intra-aortic balloon pump 
aOR = adjusted odds ratio 
CI = confidence interval 
SD = standard deviation 
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INTRODUCTION 
The optimal method of revascularization for coronary artery disease (CAD), whether it is 
percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG), has been a 
controversial and frequent topic of research for many years (1-12). Physicians consider 
numerous factors when formulating their recommendation for revascularization, including, but 
not limited to, the presence of diabetes mellitus, chronic kidney disease, systolic dysfunction, 
prior CABG, and the complexity of CAD (13-15). In recent years, clinical guidelines and 
appropriate use criteria have been developed to assist physicians in making evidence-based 
recommendations (13,14,16).  
Nevertheless, the decision to recommend surgical or percutaneous revascularization is 
complex, frequently requiring the input of general cardiologists, interventional cardiologists, and 
cardiac surgeons. Clinical guidelines advocate for a team-based, multidisciplinary, “Heart Team” 
approach to determining the optimal revascularization strategy for complex patients (13,14,16). 
Through this multidisciplinary approach, patients may be deemed ineligible for a particular 
revascularization option.  
Recent research has demonstrated that patients with unprotected left main or 
multivessel CAD who are deemed ineligible for surgical revascularization experience worse 
outcomes after PCI as compared to patients not deemed ineligible (17,18). These studies reflect 
the experiences of PCI at tertiary care institutions. Historically, surgically ineligible patients 
referred for PCI are thought to represent a high-risk cohort. The characteristics and outcomes of 
PCI in patients turned down for surgical revascularization in broad community practice have not 
been studied. Therefore, using a large regional PCI database, we sought to describe the 
characteristics and outcomes of PCI in patients with documented surgical ineligibility within a 
diverse array of PCI-capable hospitals.  
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METHODS 
We performed a retrospective analysis on data from the Blue Cross Blue Shield of 
Michigan Cardiovascular Consortium (BMC2), a regional registry of all patients undergoing PCI in 
Michigan. A more complete description of the registry, including data collection and auditing 
practices, has been described previously (19,20). Briefly, this is a prospective, multicenter, 
statewide registry of patients undergoing PCI at any of the non-federal hospitals in Michigan. 
For the current study, consecutive patients undergoing PCI between January 2010 and 
December 2014 at the 33 hospitals with on-site cardiac surgery were included. 
Patients that presented with ST-elevation myocardial infarction (STEMI) or pre-
procedural cardiac arrest were excluded due to the emergent nature of treatment and a bias 
towards PCI in these individuals. Patients with a history of CABG were excluded, as the decision 
to recommend surgical or percutaneous revascularization often hinges on unique and important 
considerations such as repeat sternotomy, graft anatomy, and conduit availability. Finally, 
patients that underwent salvage PCI were excluded given the use of PCI as a last resort in these 
critically ill patients. Salvage PCI was defined as PCI in a patient who, within ten minutes prior to 
the start of the procedure, has received chest compressions or has been on unanticipated 
extracorporeal circulatory support (21). Surgical ineligibility was defined as written 
documentation indicating that the patient was evaluated by a cardiac surgeon and felt not to be 
a surgical candidate for any reason. We did not collect information regarding the reason for 
surgical referral or for surgical ineligibility, as these reasons are often heterogeneous and poorly 
defined. We divided patients into two groups, those turned down for surgical revascularization 
and the remainder (who may or may not have been evaluated by a cardiac surgeon).  
Outcomes and Subgroup Analysis 
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All outcomes were measured during the incident hospitalization when PCI was 
performed. The primary outcome measure was in-hospital mortality attributable to any cause. 
Secondary outcomes included the development of post-procedure cardiogenic shock, 
cerebrovascular accident (CVA), contrast-induced nephropathy (CIN), and a new requirement for 
dialysis (NRD). Post-procedure cardiogenic shock and CVA were defined as per the NCDR 
CathPCI registry definition (21). CIN was defined as renal dysfunction resulting in a 0.5 mg/dL 
absolute increase in a post-procedure creatinine measurement as compared to baseline. NRD 
was defined as any new, unplanned need for dialysis after PCI. 
Clinical outcomes are reported for the overall cohort and by subgroups defined by 
percutaneously treated CAD anatomy. Diagnostic catheterization data were not routinely 
collected on all patients in the registry; therefore, we defined CAD anatomy by the site(s) of PCI 
per catheterization lab visit. Complex disease was defined as unprotected left main PCI, three-
vessel PCI, or two-vessel with proximal left anterior descending (LAD) PCI. Due to the exclusion 
of patients with prior CABG, all left main PCIs were considered unprotected. The hierarchy of 
categorization also followed the aforementioned sequence. For example, a patient who 
underwent left main and proximal LAD PCI would be classified as having left main disease, not 
two-vessel with proximal LAD disease. All other patients were categorized as having non-
complex disease. 
Statistical Analysis 
Baseline characteristics and outcomes were compared between surgically ineligible 
patients and the remainder using Pearson χ2 or Fisher’s exact test for categorical variables and 
Student t-tests for continuous variables. Continuous variables were summarized using mean ± 
SD. Outcome rates by surgical ineligibility were compared using Fisher's exact test. Pre-
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procedural risks of mortality, CIN, and need for transfusion were estimated using the BMC2 
random forest prediction models (available for review at https://bmc2.org/calculators/multi). 
The methodology and specific implementations for CIN and transfusion endpoints have been 
validated and previously described elsewhere (22,23). 
For the primary outcome of mortality, hierarchical logistic regression models were 
utilized incorporating patient baseline mortality risk and PCI-treated CAD anatomy as fixed 
effects and accounting for potential hospital level variability through the inclusion of a hospital 
random intercept. All analyses were performed using R version 3.2.1 (24). Hierarchical 
generalized mixed effects regression models were fitted using the lme4 R package (25).  
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RESULTS 
A total of 151,223 patients underwent PCI at the 33 participating centers between 
January 2010 and December 2014. Of these, 24,153 (16.0%) presented with STEMI, 2,893 (1.9%) 
experienced a pre-procedure cardiac arrest, 283 (0.2%) underwent salvage PCI, and 28,242 
(18.7%) had a history of CABG. A total of 51,853 (34.3%) patients met at least one exclusion 
criteria, leaving 99,370 patients in the overall cohort.  A total of 1,922 (1.9%) patients were 
turned down for surgery. The baseline characteristics of surgically ineligible patients and the 
remainder are presented in Table 1. The two groups were largely similar in their baseline 
characteristics, with only prior myocardial infarction and prior PCI having occurred at a greater 
frequency in patients ineligible for surgery. 
There was no significant site-level variation in the incidence of surgically ineligible 
patients across the 33 hospitals with on-site surgical backup (range: 1.5% to 2.5%; Χ
2
 = 25.5 on 
32 df; p > 0.5) (Figure 1). In-hospital mortality was similar between the two groups (0.52% vs. 
0.52%; p > 0.5; Figure 2), and no significant difference was observed after adjusting for pre-
procedural predicted risk of mortality, PCI-treated CAD anatomy, and hospital-level clustering in 
a hierarchical regression model (adjusted odds ratio [aOR] = 1.11; 95% confidence interval [CI] 
0.57 – 2.15; p > 0.5). Furthermore, no significant differences were noted in secondary outcome 
measures (Figure 2).  
 
Stratification by PCI-treated CAD anatomy 
A total of 4,438 patients were defined as having complex disease, of which 81 patients 
(1.8%) had documentation of surgical ineligibility. The majority (95.8%; n/N = 1,841/1,922) of 
surgically ineligible patients had non-complex disease (Table 2). There was no difference in the 
distribution of PCI-treated CAD anatomy between patients turned down and not turned down 
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for surgery (p > 0.5). Of note, no surgically ineligible patients underwent three-vessel PCI. No 
significant differences in primary or secondary outcomes were observed in any PCI-treated CAD 
anatomy subgroup other than left main PCI patients.  
Among patients who underwent left main PCI (n = 1,074), those deemed surgically 
ineligible (n = 20) had significantly increased rates of in-hospital mortality (20.0% vs. 5.3%; p = 
0.022), cardiogenic shock (25.0% vs. 5.1%; p = 0.004), and NRD (10.5% vs. 1.6%; p = 0.042) as 
compared to the remainder (n = 1,054; Figure 3). Of note, 40% (n/N = 4/10) of in-hospital deaths 
in all surgically ineligible patients occurred in those who underwent left main PCI. 
The effect of surgical ineligibility on mortality varied significantly between patients with 
left main PCI compared to those with other PCI-treated CAD anatomy after adjusting for 
predicted pre-procedural mortality risk, CAD anatomy, and hospital-level clustering (Likelihood 
ratio test for left main PCI by ineligibility interaction: LRT = 12.7 on 1 df, p < 0.0001). In stratified, 
adjusted hierarchical regression analysis, again adjusting for predicted baseline risk and hospital 
level clustering fit within the left main PCI subgroup, mortality was strongly associated with 
surgical ineligibility (aOR = 7.38, 95% CI 2.32 - 23.49, p < 0.001). 
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DISCUSSION 
Recent research has demonstrated that surgical ineligibility is associated with inferior 
outcomes after PCI in patients with complex CAD (17,18). Our study significantly adds to this 
body of literature through three major findings. First, it appears that broadly, PCI in patients 
deemed ineligible for surgical revascularization is safe, given that there is no significant 
difference in multiple, clinically relevant, in-hospital outcomes including death. Second, as noted 
in prior studies, individuals who were deemed ineligible for surgery and underwent left main PCI 
suffered significantly worse outcomes as compared to the rest of the cohort, highlighting the 
potential additive effect of surgical ineligibility in high-risk, complex CAD (17,18). Third, there 
was no significant variation in the frequency of PCI in surgically ineligible patients amongst a 
diverse group of PCI-capable hospitals within this region.  
 Though PCI in patients with documented surgical ineligibility appears to be safe, these 
findings must be interpreted with certain caveats. One potential reason why PCI appears safe in 
this population may be because these surgically ineligible patients were inherently deemed 
eligible for PCI by the interventional cardiologist performing the procedure. Undoubtedly, there 
are patients who are deemed ineligible for surgery and PCI, thereby never undergoing 
revascularization. The outcomes of these patients were not collected or reported. 
 When assessing the outcomes of PCI by PCI-treated CAD anatomy, we attempted to 
classify patients according to the severity of their disease by using the appropriate use criteria 
for multivessel disease as a guide (16). Patients who underwent two-vessel with proximal LAD 
PCI experienced similar outcomes when stratified by surgical ineligibility. There is a possibility 
that this finding is due to misclassification of CAD complexity, given that we classified CAD 
anatomy based on lesions treated by PCI and not native CAD at the time of diagnostic 
Page 12 of 66
Catheterization and Cardiovascular Interventions
Catheterization and Cardiovascular Interventions
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rt
ic
le
 
 
13 
 
catheterization. Therefore, patients with multivessel complex CAD who underwent staged PCI 
may have been categorized as having non-complex disease. Additionally, some patients with 
multivessel native CAD would have been categorized as having non-complex disease if they 
underwent PCI of select lesions (i.e. incomplete revascularization), if the interventional 
cardiologist felt that this would provide the optimal risk/benefit ratio. Nevertheless, the 
generally favorable outcomes in the overall population are reassuring.  
Though only 20 surgically ineligible patients underwent left main PCI, 4 (20%) died 
during the hospitalization. This surgically ineligible subgroup also had increased rates of 
cardiogenic shock and NRD. Even after adjustment, surgical ineligibility was associated with a 7-
fold increase in in-hospital mortality in this subgroup. Although the absolute number of patients 
in this subgroup is small, this finding is consistent with prior studies assessing the relationship 
between surgical ineligibility and PCI outcomes (17,18). Future studies should attempt to 
elucidate the specific, and often complex, reasons for surgical ineligibility that may confer this 
increased risk. It is also noteworthy that a substantially larger number of patients underwent left 
main PCI without being turned down for surgery and the general outcome in this cohort was 
excellent. Although the total number of patients who were referred to surgery for left main 
disease is not available, it is likely that these 20 patients represent a highly selected and unique 
subset of patients who were at a high risk of adverse outcomes from either revascularization 
strategy. 
Multiple studies have demonstrated significant hospital-level variation for a number of 
important cardiovascular outcomes (26-28). The 33 nonfederal PCI-capable hospitals in our 
statewide registry vary from community hospitals to quaternary teaching hospitals. We found 
no significant difference in the rate of PCI in surgically ineligible patients across these hospitals. 
This suggests that practice patterns are broadly similar across the state. Notably, both 
Page 13 of 66
Catheterization and Cardiovascular Interventions
Catheterization and Cardiovascular Interventions
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rt
ic
le
 
 
14 
 
interventional cardiologists and cardiac surgeons participate in statewide collaborative quality 
improvement initiatives and such practice uniformity may or may not exist across geographic 
regions that do not participate in such initiatives (29). 
Clinical guidelines advocate for the use of a multidisciplinary Heart Team approach 
when evaluating revascularization options for patients with complex CAD (13,14,16). Therefore, 
it is surprising that the vast majority of surgically ineligible patients (95.8%) had non-complex 
disease. As stated above, this number may be an overestimate due to our classification scheme. 
Nevertheless, even if we were to assume a substantial proportion of misclassification, the 
majority of patients would still likely have non-complex disease. It is unclear why these patients 
were referred for surgery, let alone deemed ineligible. It is possible that these patients may 
have had more diffuse and complex coronary lesions or other cardiac conditions such as severe 
valve disease that may have led to surgical referral. In the future, the number of patients with 
complex CAD evaluated for surgical and percutaneous revascularization options will likely 
increase as the utilization of a Heart Team approach grows (30-32). We suspect that 
documentation of these collaborative decisions will provide a better understanding of referral 
practices between cardiologists and cardiac surgeons and allow for more rigorous research into 
the effects of surgical ineligibility on patient outcomes. 
Fortunately, through the emergence of new healthcare information technologies and 
the mandate for the meaningful use of electronic health records, “big data” analytics may be 
able to help us better understand these issues in the future. For example, the application of 
natural language processing systems to electronic medical records have already resulted in 
improved prediction and detection of outcomes, and is being used to develop clinical registries 
(33-35). We imagine that the application of these technologies to the vast wealth of clinical 
information in electronic health records will ultimately allow us to obtain a more complete and 
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nuanced understanding of complex clinical decisions such as the reasons for surgical referral and 
the rationale for surgical ineligibility (or eligibility) in patients with CAD.  
There are several limitations in our study that deserve specific mention. First, as noted 
above, we may have potentially misclassified the complexity of CAD due to inherent limitations 
in the accurate collection of native CAD anatomy, requiring us to use percutaneously treated 
CAD anatomy. Second, the registry follows a rigorous definition for surgical ineligibility, and 
surgical ineligibility cannot be assigned by a cardiologist or following a “curbside” consult. We 
had no method of accounting for non-documented surgical ineligibility, but our rigorous 
definition would increase the specificity of our findings. Furthermore, as noted by Gasparovic et 
al, we believe that in order to accurately study the association between surgical ineligibility and 
PCI outcomes, cardiac surgeons, not surrogate decision-makers, should determine a patient’s 
eligibility for surgery (36). Third, we do not have data on intermediate- and long-term outcomes. 
As demonstrated previously, there may be a more substantial difference in outcomes between 
these two groups in the long-term (17,18). Fourth, despite collecting PCI information from 
multiple centers over a 4-year time period, our statistical power to detect significant differences 
in outcomes was limited by the small number of patients deemed surgically ineligible. This 
limitation underscores the need for ongoing research studying the impact of surgical ineligibility 
on PCI outcomes, and the consideration of including this variable in large, national PCI registries.  
 
CONCLUSIONS 
PCI in a broad population of surgically ineligible patients appears safe, potentially 
highlighting the discretion utilized by interventional cardiologists in selecting these patients. 
Importantly though, there is a substantial effect of surgical ineligibility on mortality in the 
subgroup of patients who underwent unprotected left main PCI, although this finding should be 
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interpreted with caution as only 20 surgically ineligible patients underwent left main PCI. Our 
findings may assist physicians and patients in more accurately estimating the risks associated 
with PCI in patients with documented surgical ineligibility. 
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Figure Legends: 
 
Figure 1: The percentage of percutaneous coronary interventions performed in surgically 
ineligible patients by hospital – The bar graph represents the percent of PCI cases performed in 
surgically ineligible patients in each hospital participating in the BMC2 registry. The sites are 
ordered from the lowest to the highest frequency site.  
PCI = percutaneous coronary intervention 
 
Figure 2: In-hospital outcome rates in all patients – Bar graphs of primary and secondary in-
hospital outcomes in all patients stratified by ineligibility for surgery. The specific outcome rate is 
noted above each bar. 
 
Figure 3: In-hospital outcome rates in the left main PCI subgroup – Bar graphs of primary and 
secondary in-hospital outcomes in patients who underwent left main PCI stratified by ineligibility 
for surgery. The specific outcome rate is noted above each bar. 
PCI = percutaneous coronary intervention 
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Table I: Baseline characteristics of surgically ineligible patients and others 
 
 Surgically 
ineligible Others 
 
Variable (n = 1,922) (n = 97,448) P value 
Age (years) 64.5 ± 11.8 64.8 ± 11.9 0.30 
Male 63.5% 63.8% 0.80 
Body mass index (kg/m
2
) 30.9 ± 7.8 30.8 ± 7.4 0.69 
Current/recent smoker 30.4% 28.5% 0.08 
Hypertension 87.0% 86.8% 0.81 
Dyslipidemia 84.9% 83.9% 0.20 
Diabetes mellitus 37.8% 37.9% 0.97 
Cerebrovascular disease 14.3% 14.2% 0.92 
Peripheral arterial disease 15.9% 14.6% 0.12 
Prior myocardial infarction 35.2% 32.1% 0.004 
Prior heart failure 15.7% 14.8% 0.27 
Prior valve surgery 1.1% 0.9% 0.40 
Prior PCI 48.0% 45.6% 0.04 
End-stage renal disease 2.5% 2.4% 0.84 
Chronic lung disease 19.1% 19.3% 0.80 
History of atrial fibrillation 10.9% 11.0% 0.83 
Current/recent gastrointestinal 
bleeding 
0.7% 1.0% 0.25 
Left ventricular ejection fraction 53.6% ± 12.0 53.4% ± 12.1 0.56 
Baseline creatinine (mg/dL) 1.16 ± 1.06 1.14 ± 0.99 0.42 
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Baseline GFR (ml/min/1.73 m
2
)* 74.97 ± 24.30 75.46 ± 24.38 0.39 
Baseline hemoglobin (g/dL) 13.42 ± 1.80 13.38 ± 1.86 0.24 
Stable angina presentation 17.1% 16.5% 0.48 
Unstable angina presentation 49.0% 48.3% 0.55 
NSTEMI presentation 24.3% 25.4% 0.28 
Cardiogenic shock† 1.0% 0.8% 0.20 
IABP 0.7% 0.8% 0.57 
Non-IABP mechanical ventricular 
support 
0.8% 0.6% 0.42 
Chronic total occlusion treated 3.5% 3.0% 0.20 
Bifurcation lesion treated 9.5% 9.2% 0.63 
Pre-procedural predicted mortality 
risk
§
 
0.57% ± 2.28 0.59% ± 2.32 0.69 
≥ 1 “high-risk” PCI-treated lesion** 55.2% 54.6% 0.63 
Emergent PCI 2.3% 2.1% 0.50 
    
All percentages represent frequencies, except for left ventricular ejection fraction and pre-
procedural predicted mortality risk, which are presented as mean ± standard deviation. Where 
nominal values are used, they are presented as mean ± standard deviation.  
GFR = glomerular filtration rate; IABP = intra-aortic balloon pump; NSTEMI = Non ST-elevation 
myocardial infarction; PCI = percutaneous coronary intervention 
*The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation was used (37). 
†Represents the frequency of patients in cardiogenic shock within 24 hours prior to the 
procedure or at the start of the procedure. 
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§ The pre-procedural risk of mortality was estimated using the BMC2 random forest prediction 
model available for review at https://bmc2.org/calculators/multi. 
**Lesion characteristics consistent with a “C lesion” as defined by the NCDR CathPCI Registry 
(21). 
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Table II: Distribution of percutaneously treated coronary artery disease anatomy stratified by 
surgical ineligibility 
 Surgically 
ineligible Others 
Percutaneously treated CAD anatomy (n = 1,922) (n = 97,448) 
Complex disease 81 
(4.2%) 
4,357 
(4.5%) 
 Left main disease 20 
(1.0%) 
1,054 
(1.1%) 
 Three-vessel disease 0 
(0.0%) 
37 
(0.0%) 
 
Two-vessel with proximal LAD disease 61 
(3.2%) 
3,266 
(3.4%) 
Non-complex disease 1,841 
(95.8%) 
93,091 
(95.5%) 
Values are n (%). 
PCI = percutaneous coronary intervention; CAD = coronary artery disease; LAD = left anterior 
descending artery 
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Figure 1: The percentage of percutaneous coronary interventions performed in surgically ineligible patients 
by hospital – The bar graph represents the percent of PCI cases performed in surgically ineligible patients in 
each hospital participating in the BMC2 registry. The sites are ordered from the lowest to the highest 
frequency site.  
PCI = percutaneous coronary intervention  
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Figure 2: In-hospital outcome rates in all patients – Bar graphs of primary and secondary in-hospital 
outcomes in all patients stratified by ineligibility for surgery. The specific outcome rate is noted above each 
bar.  
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Figure 3: In-hospital outcome rates in the left main PCI subgroup – Bar graphs of primary and secondary in-
hospital outcomes in patients who underwent left main PCI stratified by ineligibility for surgery. The specific 
outcome rate is noted  above each bar. PCI = percutaneous coronary intervention   
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Referee(s)' Comments to Author: 
 
Reviewer: 1 
 
Comments to the Author 
In the present submission, “Clinical outcomes of percutaneous coronary intervention in 
patients turned down for surgical revascularization”, Sukul et al., report results from a 
statewide registry suggesting that in-hospital outcomes among patients turned down for 
surgery and subsequently undergoing PCI are not significantly different as compared to 
outcomes in all other patients undergoing PCI.  The single exception is for surgically 
ineligible patients undergoing unprotected left main PCI, who were observed to have 
higher mortality and other complications compared to surgically eligible patients 
undergoing left main PCI. 
 
The manuscript is very well-written, and the analysis is sophisticated and appears to have 
been well-conducted. The authors’ findings add insight to our understanding of the 
outcomes of PCI in surgically ineligible patients.  
  
Suggestions for the authors:  
1) The authors might clarify in the Abstract and throughout the manuscript that when they 
refer to left main PCI in this study, they are for the most part referring to unprotected left 
main PCI, as patients with prior CABG were excluded.  I suppose that an exception to this 
might be for patients with well formed collaterals to either the LAD or circumflex artery. 
 
We appreciate the Reviewer bringing this to our attention. We have made changes to make it 
clear that left main PCI was unprotected in this study in the Abstract as well as on page 8 of the 
Methods: 
 
“Complex disease was defined as unprotected left main PCI, three-vessel PCI, or two-vessel with 
proximal left anterior descending (LAD) PCI. Due to the exclusion of patients with prior CABG, all 
left main PCIs were considered unprotected.” 
 
 
2) The authors might also clarify in the Abstract that the analysis was limited to those 
centers with on-site surgical backup. 
 
We have indicated in the Abstract that the PCIs were performed at 33 hospitals with on-site 
surgical backup. 
 
 
3) The authors might explicitly state in the Methods that patients undergoing staged PCI 
were not excluded from this analysis.  They do discuss this point, and associated 
confounding, in the Discussion.  Is it possible for the authors to identify patients 
undergoing staged PCI in this Registry, and analyze whether their exclusion changes the 
main findings? 
 
Staged PCI procedures comprised 5,618 (5.65%) of the cohort, of which 115 (2.05%) were 
surgically ineligible. Among the staged PCI procedures, there were 0/115 (0.00%) deaths in 
surgically ineligible cases, and 5/5,503 (0.09%) among the remainder (p = 0.75 for difference in 
mortality). 
 
Per the Reviewer’s request, we performed a supplementary analysis where staged PCI 
procedures were excluded from the cohort and a hierarchical generalized mixed effects 
regression model was fitted with the outcome of mortality adjusting for patient baseline mortality 
risk and PCI-treated CAD anatomy as fixed effects and accounting for potential hospital level 
variability through the inclusion of a hospital random intercept. The results were very similar to 
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what was observed for the full cohort with a mortality odds ratio (surgically ineligible vs. non-
ineligible): 1.12 (0.58 - 2.16), P = 0.74. 
 
 
4) The authors do not mention any data regarding chronic total occlusion in this 
manuscript.  Was this a variable in the registry?  If so, it should be included as a marker of 
complex CAD.  If not, the lack of data regarding CTO’s should be mentioned as a 
limitation. 
 
We defined complex coronary artery disease (CAD) using the appropriate use criteria for surgical 
revascularization in multivessel disease as a guide (1). Though this may be an imperfect 
definition of surgical coronary anatomy, we believe it is clinically applicable approach that has 
been used previously (2). We have included the complexity of the PCI-treated lesion to the 
baseline characteristics table, and below for your review. Of note, there is no significant 
difference in treated lesion complexity between surgically ineligible patients and the remainder. 
 
 Surgically ineligible 
(n = 1,922) 
Other 
(n = 97,448) P value 
Chronic total occlusion 3.5% 3.0% 0.20 
Bifurcation lesion 9.5% 9.2% 0.63 
 
 
 
5) What strikes me is the lack of any significant difference in baseline variables between 
surgically ineligible and all other patients in this analysis (in my opinion the differences in 
prior PCI and prior MI do not achieve clinical significance).  As such, it is not surprising 
that outcomes did not differ among these groups.  I worry that there is significant 
confounding here – I would expect that surgically ineligible patients would be different in 
important ways from all other patients undergoing PCI.  The confounder that seems most 
likely to me is incomplete capture of surgically ineligible patients by the registry.  The fact 
that 98% of patients undergoing unprotected left main PCI were not surgically ineligible 
supports this possibility.  The authors comment on this to a certain extent, and that 
surgically ineligible patients undergoing PCI may be “cherry picked,” so to speak, but can 
they further discuss why they think the data demonstrate no differences in characteristics 
between these two groups?  
 
 
We agree with the Reviewer. We were also surprised by the lack of substantial differences in 
characteristics between patients deemed surgically ineligible and the remainder. We speculate 
that some of this lack of difference is due to the utilization of informal (i.e. “curbside”) 
consultations that are not documented in the medical record. It may also be because some 
patients were deemed surgical ineligible due, in part, to patient preference or an inappropriate 
indication for surgery. As noted above, understanding the reasons for surgical referral and 
ineligibility should be the focus of future research.  
 
 
6) No patients deemed surgically ineligible underwent three vessel PCI, which is 
surprising.  Admittedly very few patients in the “all comers” cohort underwent three 
vessel PCI either.  The authors discuss these findings to a certain point – staged PCI 
procedures, presence of CTO and completeness of revascularization were not accounted 
for.   Given the small numbers and potential confounders related to these analyses, I 
wonder whether it would be better to simply report the findings from the overall cohorts 
and the left main PCI subgroups and remove the analysis of the “complex PCI” 
subgroup.  Table 2 could then be eliminated as well. 
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We agree with the Reviewer’s observation and were similarly surprised by the data. However we 
believe that table 2 adds important information by providing a complete landscape of PCI 
practice. We feel that this should help engender further research into why these patients were 
referred for surgery in the first place and the reason(s) why PCI was performed on only one or 
two vessels. 
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Reviewer: 2 
 
Comments to the Author 
The authors have conducted a retrospective, observational study of clinical outcomes in 
PCI patients deemed ineligible for surgery.  The data is derived from a large, state-based 
registry, and the cohort number is impressively large.  The authors report that clinical 
outcomes from this group are favorable, and there seems to be no penalty for PCI vs 
CABG.  The notable exception is for patients having LMCA PCI, who did significantly 
worse.  The general topic and findings are of interest to PCI operators, so I welcome this 
report.  The data are well presented; the discussion is coherent and well written.  Some 
specific comments below: 
 
Why have peri-procedural MI and TLR-TVR not been included in the secondary endpoint? 
The death rate for LMCA PCI is high (20%); were these cases performed with support of 
percutaneous LVAD?  Did these patients die in the cathlab, or from systemic 
complications arising thereafter?  
 
We thank the Reviewer for their insightful comments. Post-procedural myocardial infarction was 
not included as an endpoint due to the fact that only a select number of hospitals in this registry 
routinely check cardiac biomarkers after PCI, whereas other sites check cardiac biomarkers at 
the discretion of the operator or based upon the clinical situation. This variability makes the 
endpoint subject to ascertainment (surveillance) bias, and likely results in an underrepresentation 
of the true post-procedural MI rate. Therefore, we do not believe it to be prudent to include this 
endpoint in our study. Furthermore, post-discharge outcomes such as TLR/TVR, are not tracked 
in this registry. 
 
A modest proportion of patients undergoing left main PCI required mechanical support in the form 
of an intra-aortic balloon pump or other percutaneous device as depicted below. Importantly, 
there was no significant difference in the rate of mechanical support during PCI between 
surgically ineligible patients and the rest. We have included the number of patients who died in 
the catheterization lab in the table below at your request. Unfortunately, we are unable to discern 
the causes of in-hospital death, therefore, we do not know if patients died from systemic 
complications after discharge from the catheterization lab. 
 
 
 Surgically ineligible 
(n = 20) 
Other 
(n = 1,054) P value 
Intra-aortic balloon pump 3/20 (15.0%) 
157/1,054 
(14.9%) 
0.99 
Other mechanical ventricular support 8/20 (40.0%) 
275/1,054 
(26.1%) 
0.162 
Death in the catheterization lab 
0/20 
(0.0%) 
9/1,054 
(0.85%) 
0.68 
  
 
The authors detail the numerous limitations of the study.  I am especially concerned 
regarding selection and reporting bias, which I appreciate is inherent in this type of 
registry study.  In contemporary practice, surgical eligibility is generally determined by the 
“Heart Team”, especially for high-risk patients. In this study, it was determined by a single 
cardiac surgeon, which introduces significant bias, further exacerbated by initial referral 
from a single primary physician (cardiologist).  This issue should be acknowledged 
because there is a positive effect of Heart Team involvement in decision-making.  The 
findings here cannot be extrapolated to centers (such as my own), which utilize a Heart 
Team.  It would be interesting to know if surgery ineligible PCI patients who were vetted by 
their respective institutional Heart Teams, had better outcome than others. 
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We agree with the Reviewer on their assessment of biases that may be playing a role in this 
study and is inherent to registry-based research assessing real-world practice. Nevertheless, we 
would like to point out that surgical ineligibility required documentation that a cardiac surgeon 
evaluated the patient and turned him or her down for surgical revascularization. This may have 
very well occurred in the context of a “Heart Team,” though, as the Reviewer points out, it may 
also have been based upon the referral by a single cardiologist and a determination by a single 
cardiac surgeon.  
 
Currently, we are unable to capture how the decision for surgical ineligibility is made (i.e. using a 
Heart Team approach or not), though it is interesting to note that there was very little variation in 
the frequency of PCI in surgically ineligible patients by hospital site. Understanding the rationale 
for both surgical referral and surgical ineligibility may provide one with a greater ability to risk 
stratify the surgically ineligible cohort, though unfortunately we did not collect this information as 
noted in the methods section. This should undoubtedly be an area of future research as 
emphasized in our discussion. 
  
 
PCI complexity would also include CTO and bifurcation cases, yet these seem not to be 
included.   
 
We defined complex coronary artery disease (CAD) using the appropriate use criteria for surgical 
revascularization in multivessel disease as a guide (1). We realize that this may be an imperfect 
definition for surgical coronary disease, but we believe it is a clinically applicable approach that 
has been used previously (2). We have included the complexity of the PCI-treated lesion to the 
baseline characteristics table, and below for your review. 
 
 Surgically ineligible 
(n = 1,922) 
Other 
(n = 97,448) P value 
Chronic total occlusion treated 3.5% 3.0% 0.20 
Bifurcation lesion treated 9.5% 9.2% 0.63 
 
 
 
Left ventricular systolic impairment and diabetes would contribute to surgical ineligibility; 
conversely, prior PCI (implying stent failure for some) would be overall higher for the 
surgical group. Yet there were no differences for these parameter between the groups.  Is 
there an explanation for these observations? 
 
We were equally surprised by the lack of substantial differences in characteristics between 
patients deemed surgically ineligible and the remainder. As noted above, understanding the 
reasons for surgical referral and ineligibility should be the focus of future research. We believe 
that there may be substantial heterogeneity in the practice patterns dictating surgical referral and 
surgical ineligibility which requires further elucidation 
 
 
Is it possible to show Kaplan-Meier survival curves? 
 
Our registry only collects in-hospital data and no follow up data are available. Unfortunately given 
that our follow-up is of a relatively short duration, we do not believe a Kaplan-Meier survival curve 
would be useful. 
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Reviewer: 3 
 
Comments to the Author 
The authors sought to compare in-hospital PCI clinical outcomes between surgically 
ineligible patients to the remainder PCI patients. The cohort is large and the question is 
relevant.  
 
However, I have some concerns and suggestions: 
 
- Abstract - A good and appealing abstract should contain all the important information: 
population (surgically ineligible patients), intervention (PCI), control group (others), 
outcome (in-hospital mortality, cardiogenic shock, CVA, CIN and NRD) and time (in-
hospital). Methods: specify primary and secondary outcomes. Results: specify what group 
is compared to the surgically ineligible patients.  
 
We have revised the abstract to clearly delineate the pertinent information as stated above.  
 
 
- Results (page 11, line 15) and discussion (page 12, line 22): left main PCI is known to 
have worse outcomes than less complex PCI. It is not clear in the text if the surgical 
ineligible left main PCI group was compared to the remainder left main PCI or to all the 
remainders (including less complex PCI). Please specify.  
 
We have separated that paragraph so as to draw attention to the left main PCI cohort. We 
compared outcomes between patients undergoing left main PCI who were surgically ineligible (n 
= 20) as compared to those undergoing left main PCI who were not surgically ineligible (n = 
1,054). I attempted to clarify this point in the text by stating that the comparison was “among 
patients who underwent left main PCI (n = 1,074)” and provided the number of patients who were 
surgically ineligible within that group (n = 20), and those that were not (n = 1,054).  
 
 
- Conclusions: do not include references in the conclusions. Please be careful to state that 
left main PCI subgroup has a higher mortality rate because the study is underpowered for 
that issue (n=20). The authors should be concise in this section. All inferences and 
thoughts should be included in the discussion section. 
 
Thank you for your insightful comment. We have removed references and inferences from the 
conclusion. Furthermore, we have clarified the finding of increased mortality in surgically ineligible 
patients undergoing left main PCI in the following sentence: 
 
“Importantly though, there is a substantial effect of surgical ineligibility on mortality in the 
subgroup of patients who underwent left main PCI, although this finding should be interpreted 
with caution as only 20 surgically ineligible patients underwent left main PCI.” 
 
 
- Table I: What was the score used to predict mortality risk? Please specify in a footnote. 
 
-We have added a footnote to Table I specifying the BMC2 mortality risk prediction model utilized 
in this study and available for review at: https://bmc2.org/calculators/multi. 
 
 
- Figure 1 shows irrelevant information. Please reconsider including it. 
 
We respectfully disagree with the Reviewer and believe that this figure graphically demonstrates 
that our findings are not a function of specific hospitals with unusual practices, but instead driven 
by similar practices across heterogeneous institutions.  
Page 36 of 66
Catheterization and Cardiovascular Interventions
Catheterization and Cardiovascular Interventions
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rt
ic
le
 
 
- Figure 3: please specify the p value on top of each bar group. 
 
We have included the exact p-value for each comparison in Figure 3. 
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STRUCTURED ABSTRACT: 
OBJECTIVES: We examined clinical outcomes following percutaneous coronary intervention 
(PCI) in patients turned down for surgical revascularization across a broad population. 
BACKGROUND:  Prior studies suggest that surgical ineligibility is associated with increased 
mortality in patients with unprotected left main or multivessel coronary artery disease 
undergoing PCI.  
METHODS: This study included consecutive patients who underwent PCI in a multicenter 
registry in Michigan from 1/2010 – 12/2014. Surgical ineligibility required documentation 
indicating that a cardiac surgeon deemed the patient ineligible for surgery. In-hospital outcomes 
included mortality (primary outcome), cardiogenic shock, cerebrovascular accident, contrast-
induced nephropathy (CIN), and a new requirement for dialysis (NRD). 
RESULTS: Of 99,370 patients at 33 hospitals with on-site surgical backup, 1,922 (1.9%) were 
surgically ineligible. The rate of ineligibility did not vary by hospital (range: 1.5%-2.5%; p=0.79). 
Overall, there were no major differences in baseline characteristics or outcomes between 
surgically ineligible patients and the rest (i.e. non-ineligible patients): mortality (0.52% vs. 
0.52%; p>0.5), cardiogenic shock (0.68% vs. 0.73%; p>0.5), cerebrovascular accident (0.05% vs. 
0.19%; p=0.28), NRD (0.16% vs. 0.19%; p>0.5), CIN (2.7% vs. 2.3%; p=0.27). Among 1,074 
patients who underwent unprotected left main PCI, 20 (1.9%) were surgically ineligible and 
experienced increased rates of mortality (20.0% vs. 5.3%; p=0.022; adjusted OR = 7.38; p<0.001) 
and other complications as compared to the remainder.  
CONCLUSIONS: PCI in a broad population of surgically ineligible patients is generally safe. 
However, among patients who underwent unprotected left main PCI, those deemed surgically 
ineligible experienced significantly worse outcomes as compared to the rest.  
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KEY WORDS: percutaneous coronary intervention (PCI); coronary artery bypass grafting; health 
care outcomes; risk stratification; coronary artery disease 
ABSTRACT WORD COUNT: 247 (limit 250) 
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CONDENSED ABSTRACT: Using a large, multicenter, regional registry of PCI, this study examined 
the relationship between surgical ineligibility and clinical outcomes after PCI. In the overall study 
cohort (n = 99,370), PCI appears to be safe in surgically ineligible patients as there was no 
significant difference in outcomes between ineligible patients as compared to the rest. 
Importantly, surgical ineligibility was associated with worse outcomes in patients undergoing 
unprotected left main PCI.  
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ABBREVIATIONS & ACRONYMS: 
CAD = coronary artery disease 
PCI = percutaneous coronary intervention 
CABG = coronary artery bypass grafting 
BMC2 = Blue Cross Blue Shield of Michigan Cardiovascular Consortium 
STEMI = ST-elevation myocardial infarction 
NCDR = National Cardiovascular Data Registry 
NRD = new requirement for dialysis 
CVA = cerebrovascular accident 
CIN = contrast-induced nephropathy 
LAD = left anterior descending artery 
NSTEMI = Non ST-elevation myocardial infarction 
GFR = glomerular filtration rate 
IABP = intra-aortic balloon pump 
aOR = adjusted odds ratio 
CI = confidence interval 
SD = standard deviation 
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INTRODUCTION 
The optimal method of revascularization for coronary artery disease (CAD), whether it is 
percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG), has been a 
controversial and frequent topic of research for many years (1-12). Physicians consider 
numerous factors when formulating their recommendation for revascularization, including, but 
not limited to, the presence of diabetes mellitus, chronic kidney disease, systolic dysfunction, 
prior CABG, and the complexity of CAD (13-15). In recent years, clinical guidelines and 
appropriate use criteria have been developed to assist physicians in making evidence-based 
recommendations (13,14,16).  
Nevertheless, the decision to recommend surgical or percutaneous revascularization is 
complex, frequently requiring the input of general cardiologists, interventional cardiologists, and 
cardiac surgeons. Clinical guidelines advocate for a team-based, multidisciplinary, “Heart Team” 
approach to determining the optimal revascularization strategy for complex patients (13,14,16). 
Through this multidisciplinary approach, patients may be deemed ineligible for a particular 
revascularization option.  
Recent research has demonstrated that patients with unprotected left main or 
multivessel CAD who are deemed ineligible for surgical revascularization experience worse 
outcomes after PCI as compared to patients not deemed ineligible (17,18). These studies reflect 
the experiences of PCI at tertiary care institutions. Historically, surgically ineligible patients 
referred for PCI are thought to represent a high-risk cohort. The characteristics and outcomes of 
PCI in patients turned down for surgical revascularization in broad community practice have not 
been studied. Therefore, using a large regional PCI database, we sought to describe the 
characteristics and outcomes of PCI in patients with documented surgical ineligibility within a 
diverse array of PCI-capable hospitals.  
Page 44 of 66
Catheterization and Cardiovascular Interventions
Catheterization and Cardiovascular Interventions
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rt
ic
le
 
 
7 
 
METHODS 
We performed a retrospective analysis on data from the Blue Cross Blue Shield of 
Michigan Cardiovascular Consortium (BMC2), a regional registry of all patients undergoing PCI in 
Michigan. A more complete description of the registry, including data collection and auditing 
practices, has been described previously (19,20). Briefly, this is a prospective, multicenter, 
statewide registry of patients undergoing PCI at any of the non-federal hospitals in Michigan. 
For the current study, consecutive patients undergoing PCI between January 2010 and 
December 2014 at the 33 hospitals with on-site cardiac surgery were included. 
Patients that presented with ST-elevation myocardial infarction (STEMI) or pre-
procedural cardiac arrest were excluded due to the emergent nature of treatment and a bias 
towards PCI in these individuals. Patients with a history of CABG were excluded, as the decision 
to recommend surgical or percutaneous revascularization often hinges on unique and important 
considerations such as repeat sternotomy, graft anatomy, and conduit availability. Finally, 
patients that underwent salvage PCI were excluded given the use of PCI as a last resort in these 
critically ill patients. Salvage PCI was defined as PCI in a patient who, within ten minutes prior to 
the start of the procedure, has received chest compressions or has been on unanticipated 
extracorporeal circulatory support (21). Surgical ineligibility was defined as written 
documentation indicating that the patient was evaluated by a cardiac surgeon and felt not to be 
a surgical candidate for any reason. We did not collect information regarding the reason for 
surgical referral or for surgical ineligibility, as these reasons are often heterogeneous and poorly 
defined. We divided patients into two groups, those turned down for surgical revascularization 
and the remainder (who may or may not have been evaluated by a cardiac surgeon).  
Outcomes and Subgroup Analysis 
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All outcomes were measured during the incident hospitalization when PCI was 
performed. The primary outcome measure was in-hospital mortality attributable to any cause. 
Secondary outcomes included the development of post-procedure cardiogenic shock, 
cerebrovascular accident (CVA), contrast-induced nephropathy (CIN), and a new requirement for 
dialysis (NRD). Post-procedure cardiogenic shock and CVA were defined as per the NCDR 
CathPCI registry definition (21). CIN was defined as renal dysfunction resulting in a 0.5 mg/dL 
absolute increase in a post-procedure creatinine measurement as compared to baseline. NRD 
was defined as any new, unplanned need for dialysis after PCI. 
Clinical outcomes are reported for the overall cohort and by subgroups defined by 
percutaneously treated CAD anatomy. Diagnostic catheterization data were not routinely 
collected on all patients in the registry; therefore, we defined CAD anatomy by the site(s) of PCI 
per catheterization lab visit. Complex disease was defined as unprotected left main PCI, three-
vessel PCI, or two-vessel with proximal left anterior descending (LAD) PCI. Due to the exclusion 
of patients with prior CABG, all left main PCIs were considered unprotected. The hierarchy of 
categorization also followed the aforementioned sequence. For example, a patient who 
underwent left main and proximal LAD PCI would be classified as having left main disease, not 
two-vessel with proximal LAD disease. All other patients were categorized as having non-
complex disease. 
Statistical Analysis 
Baseline characteristics and outcomes were compared between surgically ineligible 
patients and the remainder using Pearson χ2 or Fisher’s exact test for categorical variables and 
Student t-tests for continuous variables. Continuous variables were summarized using mean ± 
SD. Outcome rates by surgical ineligibility were compared using Fisher's exact test. Pre-
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procedural risks of mortality, CIN, and need for transfusion were estimated using the BMC2 
random forest prediction models (available for review at https://bmc2.org/calculators/multi). 
The methodology and specific implementations for CIN and transfusion endpoints have been 
validated and previously described elsewhere (22,23). 
For the primary outcome of mortality, hierarchical logistic regression models were 
utilized incorporating patient baseline mortality risk and PCI-treated CAD anatomy as fixed 
effects and accounting for potential hospital level variability through the inclusion of a hospital 
random intercept. All analyses were performed using R version 3.2.1 (24). Hierarchical 
generalized mixed effects regression models were fitted using the lme4 R package (25).  
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RESULTS 
A total of 151,223 patients underwent PCI at the 33 participating centers between 
January 2010 and December 2014. Of these, 24,153 (16.0%) presented with STEMI, 2,893 (1.9%) 
experienced a pre-procedure cardiac arrest, 283 (0.2%) underwent salvage PCI, and 28,242 
(18.7%) had a history of CABG. A total of 51,853 (34.3%) patients met at least one exclusion 
criteria, leaving 99,370 patients in the overall cohort.  A total of 1,922 (1.9%) patients were 
turned down for surgery. The baseline characteristics of surgically ineligible patients and the 
remainder are presented in Table 1. The two groups were largely similar in their baseline 
characteristics, with only prior myocardial infarction and prior PCI having occurred at a greater 
frequency in patients ineligible for surgery. 
There was no significant site-level variation in the incidence of surgically ineligible 
patients across the 33 hospitals with on-site surgical backup (range: 1.5% to 2.5%; Χ
2
 = 25.5 on 
32 df; p > 0.5) (Figure 1). In-hospital mortality was similar between the two groups (0.52% vs. 
0.52%; p > 0.5; Figure 2), and no significant difference was observed after adjusting for pre-
procedural predicted risk of mortality, PCI-treated CAD anatomy, and hospital-level clustering in 
a hierarchical regression model (adjusted odds ratio [aOR] = 1.11; 95% confidence interval [CI] 
0.57 – 2.15; p > 0.5). Furthermore, no significant differences were noted in secondary outcome 
measures (Figure 2).  
 
Stratification by PCI-treated CAD anatomy 
A total of 4,438 patients were defined as having complex disease, of which 81 patients 
(1.8%) had documentation of surgical ineligibility. The majority (95.8%; n/N = 1,841/1,922) of 
surgically ineligible patients had non-complex disease (Table 2). There was no difference in the 
distribution of PCI-treated CAD anatomy between patients turned down and not turned down 
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for surgery (p > 0.5). Of note, no surgically ineligible patients underwent three-vessel PCI. No 
significant differences in primary or secondary outcomes were observed in any PCI-treated CAD 
anatomy subgroup other than left main PCI patients.  
Among patients who underwent left main PCI (n = 1,074), those deemed surgically 
ineligible (n = 20) had significantly increased rates of in-hospital mortality (20.0% vs. 5.3%; p = 
0.022), cardiogenic shock (25.0% vs. 5.1%; p = 0.004), and NRD (10.5% vs. 1.6%; p = 0.042) as 
compared to the remainder (n = 1,054; Figure 3). Of note, 40% (n/N = 4/10) of in-hospital deaths 
in all surgically ineligible patients occurred in those who underwent left main PCI. 
The effect of surgical ineligibility on mortality varied significantly between patients with 
left main PCI compared to those with other PCI-treated CAD anatomy after adjusting for 
predicted pre-procedural mortality risk, CAD anatomy, and hospital-level clustering (Likelihood 
ratio test for left main PCI by ineligibility interaction: LRT = 12.7 on 1 df, p < 0.0001). In stratified, 
adjusted hierarchical regression analysis, again adjusting for predicted baseline risk and hospital 
level clustering fit within the left main PCI subgroup, mortality was strongly associated with 
surgical ineligibility (aOR = 7.38, 95% CI 2.32 - 23.49, p < 0.001). 
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DISCUSSION 
Recent research has demonstrated that surgical ineligibility is associated with inferior 
outcomes after PCI in patients with complex CAD (17,18). Our study significantly adds to this 
body of literature through three major findings. First, it appears that broadly, PCI in patients 
deemed ineligible for surgical revascularization is safe, given that there is no significant 
difference in multiple, clinically relevant, in-hospital outcomes including death. Second, as noted 
in prior studies, individuals who were deemed ineligible for surgery and underwent left main PCI 
suffered significantly worse outcomes as compared to the rest of the cohort, highlighting the 
potential additive effect of surgical ineligibility in high-risk, complex CAD (17,18). Third, there 
was no significant variation in the frequency of PCI in surgically ineligible patients amongst a 
diverse group of PCI-capable hospitals within this region.  
 Though PCI in patients with documented surgical ineligibility appears to be safe, these 
findings must be interpreted with certain caveats. One potential reason why PCI appears safe in 
this population may be because these surgically ineligible patients were inherently deemed 
eligible for PCI by the interventional cardiologist performing the procedure. Undoubtedly, there 
are patients who are deemed ineligible for surgery and PCI, thereby never undergoing 
revascularization. The outcomes of these patients were not collected or reported. 
 When assessing the outcomes of PCI by PCI-treated CAD anatomy, we attempted to 
classify patients according to the severity of their disease by using the appropriate use criteria 
for multivessel disease as a guide (16). Patients who underwent two-vessel with proximal LAD 
PCI experienced similar outcomes when stratified by surgical ineligibility. There is a possibility 
that this finding is due to misclassification of CAD complexity, given that we classified CAD 
anatomy based on lesions treated by PCI and not native CAD at the time of diagnostic 
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catheterization. Therefore, patients with multivessel complex CAD who underwent staged PCI 
may have been categorized as having non-complex disease. Additionally, some patients with 
multivessel native CAD would have been categorized as having non-complex disease if they 
underwent PCI of select lesions (i.e. incomplete revascularization), if the interventional 
cardiologist felt that this would provide the optimal risk/benefit ratio. Nevertheless, the 
generally favorable outcomes in the overall population are reassuring.  
Though only 20 surgically ineligible patients underwent left main PCI, 4 (20%) died 
during the hospitalization. This surgically ineligible subgroup also had increased rates of 
cardiogenic shock and NRD. Even after adjustment, surgical ineligibility was associated with a 7-
fold increase in in-hospital mortality in this subgroup. Although the absolute number of patients 
in this subgroup is small, this finding is consistent with prior studies assessing the relationship 
between surgical ineligibility and PCI outcomes (17,18). Future studies should attempt to 
elucidate the specific, and often complex, reasons for surgical ineligibility that may confer this 
increased risk. It is also noteworthy that a substantially larger number of patients underwent left 
main PCI without being turned down for surgery and the general outcome in this cohort was 
excellent. Although the total number of patients who were referred to surgery for left main 
disease is not available, it is likely that these 20 patients represent a highly selected and unique 
subset of patients who were at a high risk of adverse outcomes from either revascularization 
strategy. 
Multiple studies have demonstrated significant hospital-level variation for a number of 
important cardiovascular outcomes (26-28). The 33 nonfederal PCI-capable hospitals in our 
statewide registry vary from community hospitals to quaternary teaching hospitals. We found 
no significant difference in the rate of PCI in surgically ineligible patients across these hospitals. 
This suggests that practice patterns are broadly similar across the state. Notably, both 
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interventional cardiologists and cardiac surgeons participate in statewide collaborative quality 
improvement initiatives and such practice uniformity may or may not exist across geographic 
regions that do not participate in such initiatives (29). 
Clinical guidelines advocate for the use of a multidisciplinary Heart Team approach 
when evaluating revascularization options for patients with complex CAD (13,14,16). Therefore, 
it is surprising that the vast majority of surgically ineligible patients (95.8%) had non-complex 
disease. As stated above, this number may be an overestimate due to our classification scheme. 
Nevertheless, even if we were to assume a substantial proportion of misclassification, the 
majority of patients would still likely have non-complex disease. It is unclear why these patients 
were referred for surgery, let alone deemed ineligible. It is possible that these patients may 
have had more diffuse and complex coronary lesions or other cardiac conditions such as severe 
valve disease that may have led to surgical referral. In the future, the number of patients with 
complex CAD evaluated for surgical and percutaneous revascularization options will likely 
increase as the utilization of a Heart Team approach grows (30-32). We suspect that 
documentation of these collaborative decisions will provide a better understanding of referral 
practices between cardiologists and cardiac surgeons and allow for more rigorous research into 
the effects of surgical ineligibility on patient outcomes. 
Fortunately, through the emergence of new healthcare information technologies and 
the mandate for the meaningful use of electronic health records, “big data” analytics may be 
able to help us better understand these issues in the future. For example, the application of 
natural language processing systems to electronic medical records have already resulted in 
improved prediction and detection of outcomes, and is being used to develop clinical registries 
(33-35). We imagine that the application of these technologies to the vast wealth of clinical 
information in electronic health records will ultimately allow us to obtain a more complete and 
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nuanced understanding of complex clinical decisions such as the reasons for surgical referral and 
the rationale for surgical ineligibility (or eligibility) in patients with CAD.  
There are several limitations in our study that deserve specific mention. First, as noted 
above, we may have potentially misclassified the complexity of CAD due to inherent limitations 
in the accurate collection of native CAD anatomy, requiring us to use percutaneously treated 
CAD anatomy. Second, the registry follows a rigorous definition for surgical ineligibility, and 
surgical ineligibility cannot be assigned by a cardiologist or following a “curbside” consult. We 
had no method of accounting for non-documented surgical ineligibility, but our rigorous 
definition would increase the specificity of our findings. Furthermore, as noted by Gasparovic et 
al, we believe that in order to accurately study the association between surgical ineligibility and 
PCI outcomes, cardiac surgeons, not surrogate decision-makers, should determine a patient’s 
eligibility for surgery (36). Third, we do not have data on intermediate- and long-term outcomes. 
As demonstrated previously, there may be a more substantial difference in outcomes between 
these two groups in the long-term (17,18). Fourth, despite collecting PCI information from 
multiple centers over a 4-year time period, our statistical power to detect significant differences 
in outcomes was limited by the small number of patients deemed surgically ineligible. This 
limitation underscores the need for ongoing research studying the impact of surgical ineligibility 
on PCI outcomes, and the consideration of including this variable in large, national PCI registries.  
 
CONCLUSIONS 
PCI in a broad population of surgically ineligible patients appears safe, potentially 
highlighting the discretion utilized by interventional cardiologists in selecting these patients. 
Importantly though, there is a substantial effect of surgical ineligibility on mortality in the 
subgroup of patients who underwent unprotected left main PCI, although this finding should be 
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interpreted with caution as only 20 surgically ineligible patients underwent left main PCI. Our 
findings may assist physicians and patients in more accurately estimating the risks associated 
with PCI in patients with documented surgical ineligibility. 
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Figure Legends: 
 
Figure 1: The percentage of percutaneous coronary interventions performed in surgically 
ineligible patients by hospital – The bar graph represents the percent of PCI cases performed in 
surgically ineligible patients in each hospital participating in the BMC2 registry. The sites are 
ordered from the lowest to the highest frequency site.  
PCI = percutaneous coronary intervention 
 
Figure 2: In-hospital outcome rates in all patients – Bar graphs of primary and secondary in-
hospital outcomes in all patients stratified by ineligibility for surgery. The specific outcome rate is 
noted above each bar. 
 
Figure 3: In-hospital outcome rates in the left main PCI subgroup – Bar graphs of primary and 
secondary in-hospital outcomes in patients who underwent left main PCI stratified by ineligibility 
for surgery. The specific outcome rate is noted above each bar. 
PCI = percutaneous coronary intervention 
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TABLES AND FIGURES 
 
Table I: Baseline characteristics of surgically ineligible patients and others 
 
 Surgically 
ineligible Others 
 
Variable (n = 1,922) (n = 97,448) P value 
Age (years) 64.5 ± 11.8 64.8 ± 11.9 0.30 
Male 63.5% 63.8% 0.80 
Body mass index (kg/m
2
) 30.9 ± 7.8 30.8 ± 7.4 0.69 
Current/recent smoker 30.4% 28.5% 0.08 
Hypertension 87.0% 86.8% 0.81 
Dyslipidemia 84.9% 83.9% 0.20 
Diabetes mellitus 37.8% 37.9% 0.97 
Cerebrovascular disease 14.3% 14.2% 0.92 
Peripheral arterial disease 15.9% 14.6% 0.12 
Prior myocardial infarction 35.2% 32.1% 0.004 
Prior heart failure 15.7% 14.8% 0.27 
Prior valve surgery 1.1% 0.9% 0.40 
Prior PCI 48.0% 45.6% 0.04 
End-stage renal disease 2.5% 2.4% 0.84 
Chronic lung disease 19.1% 19.3% 0.80 
History of atrial fibrillation 10.9% 11.0% 0.83 
Current/recent gastrointestinal 
bleeding 
0.7% 1.0% 0.25 
Left ventricular ejection fraction 53.6% ± 12.0 53.4% ± 12.1 0.56 
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Baseline creatinine (mg/dL) 1.16 ± 1.06 1.14 ± 0.99 0.42 
Baseline GFR (ml/min/1.73 m
2
)* 74.97 ± 24.30 75.46 ± 24.38 0.39 
Baseline hemoglobin (g/dL) 13.42 ± 1.80 13.38 ± 1.86 0.24 
Stable angina presentation 17.1% 16.5% 0.48 
Unstable angina presentation 49.0% 48.3% 0.55 
NSTEMI presentation 24.3% 25.4% 0.28 
Cardiogenic shock† 1.0% 0.8% 0.20 
IABP 0.7% 0.8% 0.57 
Non-IABP mechanical ventricular 
support 
0.8% 0.6% 0.42 
Chronic total occlusion treated 3.5% 3.0% 0.20 
Bifurcation lesion treated 9.5% 9.2% 0.63 
Pre-procedural predicted mortality 
risk
§
 
0.57% ± 2.28 0.59% ± 2.32 0.69 
≥ 1 “high-risk” PCI-treated lesion** 55.2% 54.6% 0.63 
Emergent PCI 2.3% 2.1% 0.50 
    
All percentages represent frequencies, except for left ventricular ejection fraction and pre-
procedural predicted mortality risk, which are presented as mean ± standard deviation. Where 
nominal values are used, they are presented as mean ± standard deviation.  
GFR = glomerular filtration rate; IABP = intra-aortic balloon pump; NSTEMI = Non ST-elevation 
myocardial infarction; PCI = percutaneous coronary intervention 
*The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation was used (37). 
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†Represents the frequency of patients in cardiogenic shock within 24 hours prior to the 
procedure or at the start of the procedure. 
§ The pre-procedural risk of mortality was estimated using the BMC2 random forest prediction 
model available for review at https://bmc2.org/calculators/multi. 
**Lesion characteristics consistent with a “C lesion” as defined by the NCDR CathPCI Registry 
(21). 
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Table II: Distribution of percutaneously treated coronary artery disease anatomy stratified by 
surgical ineligibility 
 Surgically 
ineligible Others 
Percutaneously treated CAD anatomy (n = 1,922) (n = 97,448) 
Complex disease 81 
(4.2%) 
4,357 
(4.5%) 
 Left main disease 20 
(1.0%) 
1,054 
(1.1%) 
 Three-vessel disease 0 
(0.0%) 
37 
(0.0%) 
 
Two-vessel with proximal LAD disease 61 
(3.2%) 
3,266 
(3.4%) 
Non-complex disease 1,841 
(95.8%) 
93,091 
(95.5%) 
Values are n (%). 
PCI = percutaneous coronary intervention; CAD = coronary artery disease; LAD = left anterior 
descending artery 
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Figure 1: 
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Figure 2:  
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Figure 3: 
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